Ali Keramati, MD
Clinical Cardiac Electrophysiology · Wynnewood, PANPI 1295024834
Payments from drug & device makers
What this record shows
This record is dominated by grants: $21,734 of the $27,250 with a category attached, or 79.8%. Boston Scientific accounts for 64.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $22,829 and has fallen 88.9% since, to $2,535 in 2025.
Across 91 payments — averaging $299.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$18K
- Medtronic$8K
- Abbott$1K
- Biosense Webster, Inc.$286
- Biotronik Inc.$158
- Shockwave Medical, Inc$106
- plus $280 from 9 others
Across 12 payments — averaging $9438.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$113K
What the payments were for
- Grants$21,73480%
- Travel & lodging$2,3329%
- Food & beverage$2,75410%
- Education$4292%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 29 | $17,502 |
| Medtronic(2 entities) | 25 | $7,726 |
| Abbott | 10 | $1,190 |
| Biosense Webster, Inc. | 5 | $286 |
| Biotronik Inc. | 2 | $158 |
| Shockwave Medical, Inc | 5 | $106 |
| Amgen | 4 | $73 |
| AstraZeneca | 3 | $47 |
| E.r. Squibb & Sons, L.L.C. | 2 | $47 |
| Johnson & Johnson | 1 | $22 |
| Heartflow, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Pfizer | 1 | $18 |
| Bayer | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$15,000
- EVERA MRI XT DR SURESCAN$1,147
- GENERAL TACHY$901
- GENERAL - THERAPIES$746
- AVEIR$607
- HeartMate 3 Left Ventricular Dev$208
- SPHERE-9$131
- AZURE XT DR MRI SURESCAN$119
- Watchman$113
- Carto 3$111
- Carto 3 System$109
- Confirm Rx$105
- COBALT DR MRI SURESCAN$101
How this compares
$27,250 in reported general payments places this provider in the 60th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 325 | $364,534 |
| XareltoRivaroxaban | 90 | $105,097 |
| Dofetilide | 32 | $8,951 |
| Flecainide Acetate | 93 | $7,681 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 22 | $6,362 |
| Metoprolol Succinate | 238 | $5,238 |
| Amiodarone Hcl | 112 | $3,119 |
| Propafenone Hcl ErPropafenone Hcl | 13 | $2,392 |
| SotalolSotalol Hcl | 81 | $1,753 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 27 | $676 |
| ClopidogrelClopidogrel Bisulfate | 26 | $418 |
| Metoprolol Tartrate | 31 | $173 |
| Carvedilol | 13 | $148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $364,534325 claims |
| Johnson & JohnsonXarelto | $22 | $105,09790 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Wynnewood
- Douglas EsbergWynnewood$57K
- Seth WorleyLancaster$3.7M
- John ChenaridesPittsburgh$750K
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Pugazhendhi VijayaramanWilkes Barre$594K
- Pasquale SantangeliPhiladelphia$581K
- Joshua SilversteinPittsburgh$557K
- Francis MarchlinskiPhiladelphia$469K
- Joshua CooperPhiladelphia$405K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.